{
  "ptid_time": "021_S_0984_2009-12-18",
  "img_path": "/data/qiuhui/data/adni/images/021_S_0984/2009-12-18/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 96,343 mm³, 150.1% above the reference mean. With a Z-score of 3.60 (100.0th percentile), this represents profound enlargement; hippocampal volume measures 7,667 mm³, 1.4% above the reference mean. With a Z-score of 0.14 (55.5th percentile), this represents normal volume ; whole brain volume measures 1,108,160 mm³, 2.7% above the reference mean. With a Z-score of 0.35 (63.5th percentile), this represents normal volume ; entorhinal cortex volume measures 3,704 mm³, 9.7% below the reference mean. With a Z-score of -0.66 (25.6th percentile), this represents normal volume ; fusiform gyrus volume measures 18,361 mm³, 2.5% below the reference mean. With a Z-score of -0.22 (41.5th percentile), this represents normal volume ; middle temporal gyrus volume measures 22,773 mm³, 6.7% above the reference mean. With a Z-score of 0.60 (72.7th percentile), this represents normal volume . ",
  "text_data": "Age is 79.6 years. Gender is Male. Education: 14 years. MMSE: 30.0. Logical Memory: 11.0. APOEε4 alleles: 1.0. Biomarker levels: Amyloid beta: 322.00 pg/mL (moderate reduced); Total tau: 360.20 pg/mL (moderate elevated); Phosphorylated tau: 40.67 pg/mL (significant elevated). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The data shows profound ventricular enlargement (Z-score 3.60), which is strongly suggestive of significant brain atrophy, particularly in the context of elevated P-tau and moderate Aβ reduction—consistent with Alzheimer’s pathology. However, hippocampal and whole-brain volumes are within normal ranges, and the MMSE score of 30 indicates intact cognitive function.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely due to Alzheimer’s pathology, given biomarker profile).  \n\n**Confidence:** **Medium** (high biomarker evidence of Alzheimer’s pathology, but cognitive performance remains intact, making early MCI more likely than dementia).  \n\n*Note:* The discrepancy between structural atrophy (ventricular enlargement) and preserved cognition suggests a preclinical or early symptomatic stage. Close monitoring is warranted.",
  "timestamp": "2025-07-26T01:35:45.480867"
}